Copyright
©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1407-1416
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1407
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1407
NAFL (n = 36) | NASH (n = 51) | Cirrhosis (n = 17) | F/H | P value | |
FBG | 5.65 (5.20, 6.17) | 6.07 (5.49, 6.64) | 5.04 (4.86, 6.87) | 4.413 | 0.110 |
CHO | 5.50 (4.72, 6.36) | 5.71 (5.06, 6.88) | 5.14 (4.24, 6.11) | 3.614 | 0.164 |
TG | 1.44 (0.97, 1.69)b | 1.93 (1.46, 2.46) | 1.25 (0.97, 1.46)c | 21.567 | 0.000 |
HDL | 1.47 (1.26, 1.79) | 1.37 (1.24, 1.53) | 1.42 (1.15, 1.56) | 3.219 | 0.200 |
LDL | 3.59 (2.08, 4.42) | 3.82 (3.03, 4.57) | 3.23 (2.54, 3.92) | 4.738 | 0.094 |
ALT | 31.55 (21.80, 63.45)d | 83.50 (50.00, 156.60) | 33.30 (16.95, 73.95)e | 20.514 | 0.000 |
AST | 24.00 (18.33, 35.10) | 46.00 (34.10, 76.00)f | 42.70 (24.35, 53.50)g | 26.408 | 0.000 |
ALP | 79.50 (68.00, 100.23) | 77.80 (66.30, 87.30) | 82.60 (70.20, 107.35) | 0.866 | 0.648 |
GGT | 89.95 (39.53, 129.03) | 69.00 (45.50, 100.90) | 58.80 (30.95, 93.45) | 1.718 | 0.424 |
TBIL | 15.10 (12.23, 25.15) | 13.90 (12.20, 16.60) | 17.81 (12.10, 22.75) | 5.088 | 0.079 |
DBIL | 1.70 (1.40, 3.85) | 1.90 (1.40, 2.40) | 2.20 (1.20, 2.95) | 0.446 | 0.800 |
IgG | 12.16 (10.64, 13.52) | 10.95 (10.04, 13.09) | 11.77 (9.83, 15.33) | 2.586 | 0.275 |
IgM | 0.89 (0.72, 1.21) | 0.85 (0.60, 1.09) | 1.07 (0.85, 1.36) | 3.501 | 0.174 |
IgA | 2.46 ± 0.89a | 2.72 ± 0.88 | 3.21 ± 1.13 | 3.839 | 0.025 |
- Citation: Zhu YJ, Zhang Y, Rao Y, Jiang Y, Liu YG, Li JZ, Yuan JQ, Zhao Y, Zheng WW, Ma L, Wang CY, Li J. Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology. World J Hepatol 2024; 16(12): 1407-1416
- URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1407.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1407